E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers

HB Park, KH Baek - Biochimica et Biophysica Acta (BBA)-Reviews on …, 2022 - Elsevier
The mitogen-activated protein kinase (MAPK) signaling pathway is the primary regulatory
module of various cellular processes such as cell proliferation, differentiation, and stress …

TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells

JA Woznicki, N Saini, P Flood, S Rajaram, CM Lee… - Cell death & …, 2021 - nature.com
Rewiring of host cytokine networks is a key feature of inflammatory bowel diseases (IBD)
such as Crohn's disease (CD). Th1-type cytokines—IFN-γ and TNF-α—occupy critical nodes …

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours

KJA Bigos, CG Quiles, S Lunj, DJ Smith… - Frontiers in …, 2024 - frontiersin.org
Hypoxia is a common feature of solid tumours affecting their biology and response to
therapy. One of the main transcription factors activated by hypoxia is hypoxia-inducible …

Discovery of novel histone deacetylase 6 (HDAC6) inhibitors with enhanced antitumor immunity of anti-PD-L1 immunotherapy in melanoma

X Peng, L Li, J Chen, Y Ren, J Liu, Z Yu… - Journal of medicinal …, 2022 - ACS Publications
A series of 2-phenylthiazole analogues were designed and synthesized as potential histone
deacetylase 6 (HDAC6) inhibitors based on compound 12c (an HDAC6/tubulin dual inhibitor …

Targeting UBE2T potentiates gemcitabine efficacy in pancreatic cancer by regulating pyrimidine metabolism and replication stress

X Jiang, Y Ma, T Wang, H Zhou, K Wang, W Shi, L Qin… - Gastroenterology, 2023 - Elsevier
Background & Aims Although small patient subsets benefit from current targeted strategies
or immunotherapy, gemcitabine remains the first-line drug for pancreatic cancer (PC) …

Targeted regulated cell death with small molecule compounds in colorectal cancer: Current perspectives of targeted therapy and molecular mechanisms

R Li, Y Wu, Y Li, W Shuai, A Wang, Y Zhu, X Hu… - European Journal of …, 2023 - Elsevier
Colorectal cancer (CRC), a tumor of the digestive system, is characterized by high
malignancy and poor prognosis. Currently, targeted therapy of CRC is far away from …

ATF6α contributes to rheumatoid arthritis by inducing inflammatory cytokine production and apoptosis resistance

L Ge, T Wang, D Shi, Y Geng, H Fan, R Zhang… - Frontiers in …, 2022 - frontiersin.org
Objective The contribution of activating transcription factor 6α (ATF6α) in rheumatoid arthritis
(RA) pathogenesis, especially on fibroblast-like synoviocytes (FLSs), has been suggested …

Targeting Inhibitor of Apoptosis Proteins to Overcome Chemotherapy Resistance—A Marriage between Targeted Therapy and Cytotoxic Chemotherapy

T Barroso, C Melo-Alvim, LA Ribeiro… - International Journal of …, 2023 - mdpi.com
Precision oncology is the ultimate goal of cancer treatment, ie, to treat cancer and only
cancer, leaving all the remaining cells and tissues as intact as possible. Classical …

Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

F Liu, J Chen, K Li, H Li, Y Zhu, Y Zhai, B Lu, Y Fan… - Molecular Cancer, 2024 - Springer
Ubiquitination, a pivotal posttranslational modification of proteins, plays a fundamental role
in regulating protein stability. The dysregulation of ubiquitinating and deubiquitinating …

Discovery of pan-IAP degraders via a CRBN recruiting mechanism

S Park, D Kim, W Lee, JH Cho, S Kim, GS Lee… - European Journal of …, 2023 - Elsevier
Inhibitors of apoptosis proteins (IAPs), defined by the presence of baculovirus IAP repeat
(BIR) protein domain, are critical regulators of cell survival and cell death processes …